A lot of clonazepam orally disintegrating tablets (Lot No 550147301) has been recalled due to mislabeling with incorrect strength on the carton. Clonazepam can be used to treat seizures, as well as panic and anxiety disorders. The product labeling shows the product strength as 0.125 mg and not 0.25 mg due to an error at a third-party packager. Individuals who are inadvertently prescribed a two-fold overdose of clonazepam would be at risk for the adverse effects of significant sedation, dizziness, ataxia, and confusion. There is reasonable probability for significant, possibly life-threatening, respiratory depression especially for patients with concomitant pulmonary disease, patients who have prescribed dosing near maximal dosing, and patients also taking other medications that could cause additional respiratory depression.
